Bayer Cipro
Executive Summary
Ciprofloxacin in sodium chloride 0.9% and ciprofloxacin in dextrose 5% receive FDA approval for new indications for treatment of acute sinusitis and chronic bacterial prostatitis infections. The product's tablet formulation is already approved for the indications ("The Pink Sheet" Oct. 12, In Brief)